Skip to main content

Telehealth

By HIMSS TV | 10:19 am | February 25, 2026
Ovatient CEO Michael Dalton recommends that states use Rural Health Transformation Program money to move beyond hospital-centric care models and supplement local health services with virtual-first primary and specialty care.
By Jessica Hagen | 03:57 pm | February 12, 2026
The funding will help the company scale its AI-powered, in-network virtual psychiatry platform, which employs more than 800 full-time psychiatrists.
By Jessica Hagen | 06:14 pm | February 05, 2026
The company has filed to list its Class A shares as it looks to scale its AI- and blockchain-enabled telehealth platform after U.S. expansion and private financing.
By Andrea Fox | 04:08 pm | January 30, 2026
"It's a positive moment," says Kyle Zebley, ATA's CEO and executive director of ATA Action, in a conversation about health tech policy advances and the organization's strategies for 2026.
By Jessica Hagen | 08:00 am | January 30, 2026
Following the acquisition, April Koh will continue as CEO to lead Spring Health and Harry Ritter will remain CEO of Alma as the brands operate separately.
By Jessica Hagen | 07:00 am | January 30, 2026
The partnership allows individuals to access an at-home preventive health test and, if needed, connect to One Medical’s hybrid primary care services for ongoing treatment.
By Adam Ang | 04:34 pm | January 12, 2026
Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.
By HIMSS TV | 10:11 am | January 07, 2026
Sutter Health's Dr. Richard Milani and Epic's Trevor Berceau talk about Sutter's chronic care program, which integrates readings from remote monitoring devices into the EHR to give doctors continuous insight into patients' conditions.
By HIMSS TV | 10:06 am | January 02, 2026
Sallie Gustafson, Murj's director of medical affairs, says Emory used smart remote monitoring technology that integrates with EHR systems to increase billable remote cardiac services by 52% despite minimal patient growth.
By Jessica Hagen | 11:48 am | December 31, 2025
The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff."